# Episode 138: Follicular Lymphoma Series, Pt 3 - Relapsed/Refractory Management (non-cellular therapy options)

Page: https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-138-follicular-lymphoma-series-pt-3-relapsed-refractory-management-non-cellular-therapy-options
Text version: https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-138-follicular-lymphoma-series-pt-3-relapsed-refractory-management-non-cellular-therapy-options.md
Podcast: [The Fellow on Call: The Heme/Onc Podcast](https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989)
Published: 2025-09-10T08:00:00+00:00
Episode link: https://www.thefellowoncall.com/tfocpodcast/follicularrelapsedrefractory1
Audio file: https://static1.squarespace.com/static/61b273ac9be6aa2250498c9e/t/68c057a791b42b54375b33d0/1758053073979/The+Fellow+On+Call+-+Follicular+Lymphoma+RR+-+Mix_FINAL.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-138-follicular-lymphoma-series-pt-3-relapsed-refractory-management-non-cellular-therapy-options

## Resource

This week, we shift our focus to talking about relapsed/refractory follicular lymphoma. In this episode, we will specifically discuss treatment options other than cellular therapy, which will be an upcoming episode. If you have not done so, we highly recommend listening to part 1 and part 2 of this follicular lymphoma series so that you can better follow this week’s conversation! Episode contents: - What is the role of rituximab maintenance therapy? - What does surveillance after therapy look like? - What are options for treatment of patients who have relapsed follicular lymphoma? ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Google Podcast

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-138-follicular-lymphoma-series-pt-3-relapsed-refractory-management-non-cellular-therapy-options/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-138-follicular-lymphoma-series-pt-3-relapsed-refractory-management-non-cellular-therapy-options.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.